Last update :
28/04/2024
References   References 1913  
Type : Manufacturer

Research teams :
Authors :
Title : Gemtuzumab ozogamicin (Mylotarg® - Summary of Product Characteristics)
Reference : Pfizer Europe 2020

Level of Evidence : 
Manufacturer's stability data
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
InjectionGemtuzumab ozogamicin Anticancer drug
Stability in solutions Glass Water for Injection 1 mg/ml 2-8°C Protect from light
16 Hour
Stability in solutions Glass Water for Injection 1 mg/ml <30°C Protect from light
3 Hour
Stability in solutions Polyvinyl chloride Sodium chloride 0,9% 0,075 >>0,234 mg/ml 2-8°C Protect from light
18 Hour
Stability in solutions Polyvinyl chloride Sodium chloride 0,9% 0,075 >>0,234 mg/ml <30°C Protect from light
6 Hour
Stability in solutions Polyolefine Sodium chloride 0,9% 0,075 >>0,234 mg/ml 2-8°C Protect from light
18 Hour
Stability in solutions Polyolefine Sodium chloride 0,9% 0,075 >>0,234 mg/ml <30°C Protect from light
6 Hour
Stability in solutions Ethylene vinyl acetate Sodium chloride 0,9% 0,075 >>0,234 mg/ml 2-8°C Protect from light
18 Hour
Stability in solutions Ethylene vinyl acetate Sodium chloride 0,9% 0,075 >>0,234 mg/ml <30°C Protect from light
6 Hour

  Mentions Légales